Testing effectiveness (Phase 2)Study completedNCT01358812
What this trial is testing
FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer
Who this might be right for
Metastatic Colo-rectal Cancer
Gruppo Oncologico del Nord-Ovest 37